nordefrin has been researched along with Chronic Disease in 1 studies
Nordefrin: A norepinephrine derivative used as a vasoconstrictor agent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tyni-Lenné, R | 1 |
| Dencker, K | 1 |
| Gordon, A | 1 |
| Jansson, E | 1 |
| Sylvén, C | 1 |
1 trial available for nordefrin and Chronic Disease
| Article | Year |
|---|---|
Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure.
Topics: Analysis of Variance; Chronic Disease; Exercise Test; Exercise Therapy; Female; Heart Failure; Human | 2001 |